Heart Disease News and Research

Latest Heart Disease News and Research

Risedronate versus Alendronate study

The largest retrospective, observational study comparing two osteoporosis therapies on the basis of fracture reduction was presented today at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Porto, Portugal.

3 Apr 2007

Researchers discover factor that controls blood sugar's manufacture in a novel way

Researchers have discovered a factor that controls blood sugar's manufacture in a novel way: by limiting the supply of its building blocks. The findings are reported in the April issue of the journal Cell Metabolism, published by Cell Press.

3 Apr 2007

Filtering white cells from donor blood before transfusion is much safer for patients

The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.

3 Apr 2007

Antisocial behaviour in boys leads to poor health in men

A study of over 500 men born in the early 70s in Dunedin reveals that the costs associated with antisocial behaviour may be much higher than previously thought. The research led by scientists from the MRC Social, Genetic and Developmental Psychiatry Centre based at the Institute of Psychiatry, King's College London is published in Archives of General Psychiatry.

3 Apr 2007

Embolic protection and platelet inhibition during renal artery stenting

High blood pressure is the most common chronic medical condition in the United States, and the most common identifiable cause is narrowing of a kidney artery, called renal artery stenosis.

3 Apr 2007

Long-term safety of drug-eluting stents in off-label use

Research presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La, paints a picture of the "real world" use of drug-eluting stents and offers new insight into the connection between blood clotting, or thrombosis, in the stent - a dangerous complication - and adherence and responsiveness to anti-clotting medication.

3 Apr 2007

Advances in clinical cardiology

Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.

3 Apr 2007

Sodium Bicarbonate vs. Sodium Chloride in persons undergoing coronary angiography

In patients undergoing cardiac catheterization, contrast dye injection can sometimes cause contrast-induced nephropathy (CIN), otherwise known as acute renal failure.

3 Apr 2007

Where you live might play a bigger role in your risk for heart disease than your ethnicity or race

New research reveals that rural residents were more knowledgeable about healthy eating and heart disease risk than urban residents, but that urban residents were more motivated and optimistic about getting healthy.

3 Apr 2007

Trial of percutaneous coronary intervention added to optimal medical therapy in patients with stable coronary heart disease

Percutaneous coronary interventions (PCI) involve opening partially blocked arteries to improve blood flow to the heart. These procedures are performed more than 1 million times a year.

3 Apr 2007

We need to balance out our intake of omega-6 and omega-3 fatty acids

A new study suggests that people whose diets contain dramatically more of one kind of polyunsaturated fatty acid than another may be at greater risk for both clinical depression and certain inflammatory diseases.

3 Apr 2007

New blood thinner thrombin-receptor antagonist may work without bleeding risk

When studying a new blood thinner, one of the first signs the drug is working is seeing a slight increase in minor bleeding, nose bleeds and bruising, an inconvenient side effect of preventing the blood clots that are the leading cause of heart attack and stroke.

3 Apr 2007

Dual renin system blocking drug combo provides additional blood pressure-lowering effects

A combination of two medicines that act against the effects of the enzyme renin are more effective in lowering blood pressure than either of the medicines alone, according to a study presented today at the American College of Cardiology's 56th Annual Scientific Session.

2 Apr 2007

$Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock$

Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock

Patients with acute coronary syndromes (ACS), such as heart attack and recent-onset chest pain, remain at considerable risk of experiencing further serious cardiovascular problems despite improvements in care.

2 Apr 2007

Tilarginine does not reduce risk of death after heart attack

The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.

2 Apr 2007

Effect of Torcetrapib on the progression of coronary atherosclerosis

Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).

2 Apr 2007

Addition of torcetrapib to statin therapy has no benefit for atherosclerosis progression

For some patients with high cholesterol, even the most aggressive treatment with statin drugs fails to prevent coronary artery disease.

2 Apr 2007

Chemists improve antioxidant content of pizza dough

In an effort to improve health, many popular foods are undergoing a more nutritious make-over.

2 Apr 2007

How the brain processes pain location

Is that pain in your chest a heart attack or indigestion? New research from Wake Forest University School of Medicine reveals that more areas of the brain than previously thought are involved in determining the location of pain.

2 Apr 2007

Adding estradiol to a polymer-free rapamycin-eluting stent is not associated with any measurable benefit

Patients admitted to the hospital with acute coronary syndromes (ACS) are often treated with a catheter-based procedure known as percutaneous coronary intervention (PCI), during which a stent is inserted into an occluded or narrowed coronary artery to restore blood flow to and from the heart.

2 Apr 2007

Heart Disease News and Research

Latest Heart Disease News and Research

Risedronate versus Alendronate study

Researchers discover factor that controls blood sugar's manufacture in a novel way

Filtering white cells from donor blood before transfusion is much safer for patients

Antisocial behaviour in boys leads to poor health in men

Embolic protection and platelet inhibition during renal artery stenting

Long-term safety of drug-eluting stents in off-label use

Advances in clinical cardiology

Sodium Bicarbonate vs. Sodium Chloride in persons undergoing coronary angiography

Where you live might play a bigger role in your risk for heart disease than your ethnicity or race

Trial of percutaneous coronary intervention added to optimal medical therapy in patients with stable coronary heart disease

We need to balance out our intake of omega-6 and omega-3 fatty acids

New blood thinner thrombin-receptor antagonist may work without bleeding risk

Dual renin system blocking drug combo provides additional blood pressure-lowering effects

Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock

Tilarginine does not reduce risk of death after heart attack

Effect of Torcetrapib on the progression of coronary atherosclerosis

Addition of torcetrapib to statin therapy has no benefit for atherosclerosis progression

Chemists improve antioxidant content of pizza dough

How the brain processes pain location

Adding estradiol to a polymer-free rapamycin-eluting stent is not associated with any measurable benefit

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Heart Disease News and Research

Latest Heart Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in